Nodular basal cell carcinoma: when in doubt, cut it out.
Journal of Drugs in Dermatology : JDD 2007 December
Treating superficial basal cell carcinomas (BCCs) with photodynamic therapy or topical imiquimod can provide effective results in situations where an excisional approach is contraindicated or undesirable. Numerous studies have sought to test these treatments for nodular BCCs. Recent larger studies better define the efficacy of these alternative modalities. With treatment failures expected in at least 25% of patients, these approaches are not comparable to surgery. At the same time, it appears that cosmetic outcomes are superior to excisional approaches.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app